Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002068195-26-000001
Filing Date
2026-03-03
Accepted
2026-03-03 16:33:53
Documents
1
Period of Report
2026-03-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1772573628.html 4  
1 FORM 4 wk-form4_1772573628.xml 4 6023
  Complete submission text file 0002068195-26-000001.txt   7446
Mailing Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036
Business Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036 503-299-1150
Schrodinger, Inc. (Issuer) CIK: 0001490978 (see all company filings)

EIN.: 954284541 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036
Business Address
Jain Rachit (Reporting) CIK: 0002068195 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39206 | Film No.: 26715108